or Try an Advanced Search...

    Technical Analysis for PAR - Paradigm Biopharmaceuticals Ltd

    Grade Last Price % Change Price Change
    D 0.280 3.70% 0.010
    PAR closed up 3.7 percent on Tuesday, May 14, 2024, on 73 percent of normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical PAR trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    Fell Below 20 DMA Bearish 3.70%
    Crossed Above 20 DMA Bullish 0.00%
    Gapped Up Strength 0.00%
    20 DMA Resistance Bearish 3.70%
    MACD Bullish Signal Line Cross Bullish 3.70%
    NR7 Range Contraction 9.80%
    Narrow Range Bar Range Contraction 9.80%
    Lower Bollinger Band Walk Weakness 9.80%
    Inside Day Range Contraction 9.80%
    Older End-of-Day Signals for PAR ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 13 hours ago
    Rose Above 20 DMA about 13 hours ago
    Up 5% about 13 hours ago
    Up 2% about 13 hours ago
    Up 3% about 13 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PAR Chart by TradingView
    Basic chart:

    Profile

    Paradigm Biopharmaceuticals Limited is a biopharmaceutical company focused on repurposing the drug pentosan polysulfate sodium (PPS) for the treatment of inflammation. The Company is engaged in researching and developing therapeutic products for human use. The Company is a drug repurposing company, which seeks to find new uses for old drugs. The Company has commenced the open labelled Phase II clinical trial, investigating the role of the drug PPS in treating traumatic Bone Marrow Lesions. The Company's Rhinosul has properties consisting of both histamine stabilizing and anti-inflammatory properties. The Company focuses on repurposing PPS under ZILOSUL name, as a treatment for bone marrow edema (BME) lesions following traumatic injury.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Drugs Pharmaceuticals Clinical Trial Biopharmaceutical Medical Specialties Pharmaceutical Industry Therapeutic Product Therapeutic Products Medication Organ Systems Inflammation Osteochondritis Dissecans

    Is PAR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.095
    52 Week Low 0.23
    Average Volume 733,690
    200-Day Moving Average 0.480
    50-Day Moving Average 0.321
    20-Day Moving Average 0.273
    10-Day Moving Average 0.265
    Average True Range 0.023
    RSI (14) 48.19
    ADX 28.0
    +DI 20.136
    -DI 24.977
    Chandelier Exit (Long, 3 ATRs) 0.250
    Chandelier Exit (Short, 3 ATRs) 0.300
    Upper Bollinger Bands 0.307
    Lower Bollinger Band 0.240
    Percent B (%b) 0.6
    BandWidth 24.442
    MACD Line -0.014
    MACD Signal Line -0.018
    MACD Histogram 0.0045
    Fundamentals Value
    Market Cap 63.85 Million
    Num Shares 228 Million
    EPS -0.11
    Price-to-Earnings (P/E) Ratio -2.57
    Price-to-Sales 0.00
    Price-to-Book 6.20
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.310
    Resistance 3 (R3) 0.310 0.300 0.305
    Resistance 2 (R2) 0.300 0.292 0.300 0.303
    Resistance 1 (R1) 0.290 0.288 0.295 0.290 0.302
    Pivot Point 0.280 0.280 0.283 0.280 0.280
    Support 1 (S1) 0.270 0.272 0.275 0.270 0.258
    Support 2 (S2) 0.260 0.268 0.260 0.257
    Support 3 (S3) 0.250 0.260 0.255
    Support 4 (S4) 0.250